Mortality from Heart Failure with Mid-Range Ejection Fraction.BACKGROUND
 The prognostic importance of the classification 'heart failure (HF) with mid-range ejection fraction (EF)' remains uncertain.


 To analyze the clinical characteristics, comorbidities, complications, and in-hospital and late mortality of patients classified as having HF with mid-range EF (HFmrEF - EF: 40%-49%), and to compare them to those of patients with HF with preserved EF (HFpEF - EF > 50%) and with HF with reduced EF (HFrEF - EF < 40%) on admission for decompensated HF.


 Ambispective cohort of patients admitted to the cardiac intensive care unit due to decompensated HF.  Clinical characteristics, comorbidities, complications, and in-hospital and late mortality were assessed.  The software R was used, with a 5% significance, for the tests chi-square, analysis of variance, Cox multivariate, and Kaplan-Meier survival curve, in addition to machine-learning techniques (Elastic Net and survival tree).


 RESULTS
 519 individuals were included between September 2011 and June 2019 (mean age, 74.87 ± 13.56 years; 57.6% were men).  The frequencies of HFpEF, HFmrEF and HFrEF were 25.4%, 27% and 47.6%, respectively.  Previous infarction was more frequent in HFmrEF.  The mean follow-up time was 2.94 ± 2.55 years, with no statistical difference in mortality between the groups (53.8%, 52.1%, 57.9%).  In the survival curve, there was difference between neither the HFpEF and HFmrEF groups, nor the HFpEF and HFrEF groups, but between the HFmrEF and HFrEF groups.  Age over 77 years, previous HF, history of readmission, dementia and need for vasopressors were associated with higher late mortality in the survival tree.


 The EF was not selected as a variable associated with mortality in patients with decompensated HF.
R
Mortality from Heart Failure with Mid-Range Ejection Fraction.BACKGROUND
 The prognostic importance of the classification 'heart failure (HF) with mid-range ejection fraction (EF)' remains uncertain.


 To analyze the clinical characteristics, comorbidities, complications, and in-hospital and late mortality of patients classified as having HF with mid-range EF (HFmrEF - EF: 40%-49%), and to compare them to those of patients with HF with preserved EF (HFpEF - EF > 50%) and with HF with reduced EF (HFrEF - EF < 40%) on admission for decompensated HF.


 Ambispective cohort of patients admitted to the cardiac intensive care unit due to decompensated HF.  Clinical characteristics, comorbidities, complications, and in-hospital and late mortality were assessed.  The software R was used, with a 5% significance, for the tests chi-square, analysis of variance, Cox multivariate, and Kaplan-Meier survival curve, in addition to machine-learning techniques (Elastic Net and survival tree).


 RESULTS
 519 individuals were included between September 2011 and June 2019 (mean age, 74.87 ± 13.56 years; 57.6% were men).  The frequencies of HFpEF, HFmrEF and HFrEF were 25.4%, 27% and 47.6%, respectively.  Previous infarction was more frequent in HFmrEF.  The mean follow-up time was 2.94 ± 2.55 years, with no statistical difference in mortality between the groups (53.8%, 52.1%, 57.9%).  In the survival curve, there was difference between neither the HFpEF and HFmrEF groups, nor the HFpEF and HFrEF groups, but between the HFmrEF and HFrEF groups.  Age over 77 years, previous HF, history of readmission, dementia and need for vasopressors were associated with higher late mortality in the survival tree.


 The EF was not selected as a variable associated with mortality in patients with decompensated HF.
R